Bayer and Rad AI have announced a collaboration to bring Rad AI’s advanced AI radiology operational solutions to Bayer’s Calantic Digital Solution customers.
Calantic Digital Solutions is a suite of digital radiology AI-enabled clinical and operational applications that help radiologists and their teams at critical steps within the Radiology suite.
The Calantic platform is a vendor-neutral, cloud-hosted platform that involves a growing number of applications designed to support prioritisation, lesion detection and quantification.
It also includes apps that automate routine tasks and measurements and improve workflows in Radiology suites.
The platform uses a curation approach to select apps based on structured assessment criteria.
Rad AI’s speech recognition reporting solution, AI patient follow-up management, and automated radiology impression generation tools complement Bayer’s Calantic platform.
The technologies will enable more hospitals and health systems to benefit from Rad AI’s generative AI capabilities, said the Germany-based healthcare company.
Bayer Radiology digital solutions senior vice-president Rich Dewit said: “Our customers consistently convey to us that a clear ROI from the use of AI will help to increase confidence and adoption.
“Demonstrating ROI via operational applications like those on Bayer’s Calantic Digital Solutions platform is often an easier path, which is why Bayer is excited to enter into this agreement with Rad AI.
“This technology has the ability to help physicians optimize and streamline their radiology reporting, and deliver benefits for the patient and the health system.”
The collaboration enables Radiology suites to make use of operational Radiology AI applications and integrate a scalable deployment platform through one vendor.
Rad AI Reporting uses generative AI to help radiologists create and organise radiology reports faster, allowing them to focus on reading studies and adding stable findings from prior reports.
The Rad AI Omni Impressions creates a personalised radiology report impressions from dictated findings, customised to each radiologist’s language preferences.
The Rad AI Continuity automates the follow-up process for incidental findings, helping to promote timely patient follow-up, and potentially increasing imaging revenue for health systems.
Rad AI co-founder and CEO Doktor Gurson: “Rad AI and Bayer are dedicated to pioneering innovations that serve hospitals and health systems, allowing for greater access to these advanced technologies. This relationship allows for expanded use of our cutting-edge solutions in hospitals across the country.”
